John Votto is a Respiratory physician. OpenAlex indexes 35 publications with 3,574 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2150 Corbin Ave
New Britain, CT 060532266
Telephone
860-832-6248Registry record last updated 8 Jul 2007.
Clinical trials
- Sodium Pyruvate Therapy in COPD Patients
Sponsor: Emphycorp
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Baxter HealthcareProgram year20252 payments
- Insmed, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
52.6%beta2-Adrenergic Agonist52.6%Albuterol Sulfate Hfa71%Ventolin Hfa29%Part D<11 patientsMetabolism & gastrointestinal
24.4%Corticosteroid24.4%Prednisone100%Part D<11 patientsNervous system
23.1%Antihistamine23.1%Hydroxyzine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- One-Year Recovery Among Survivors of Prolonged Severe COVID-19: A National Multicenter Cohort
Critical Care Medicine
2024 - Six Minute Walk Test Changes during Long-Term Acute Care Hospital Rehabilitation for Patients Post COVID-19
Archives of Physical Medicine and Rehabilitation
2022 - Time spent in prior hospital stay and outcomes for ventilator patients in long-term acute care hospitals
BMC Pulmonary Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”